Target intelligence / Profile preview

Signal recognition particle receptor subunit alpha (SRPRA)

Target
SRPRA
Molecular classification
Receptor, Peripheral membrane GTPase, Component of the protein translocation machinery of the endoplasmic reticulum, Member of the small GTPase superfamily
01

Overview

Signal recognition particle receptor subunit alpha (SRPRA) is the peripheral membrane GTPase subunit of the signal recognition particle (SRP) receptor, a heterodimeric complex associated with the rough endoplasmic reticulum (ER) in eukaryotic cells[1][5]. This protein, together with its partner subunit SRP receptor beta (SRPRB), mediates the GTP-dependent targeting and docking of ribosome-nascent chain complexes—specifically those containing secretory or membrane proteins recognized by signal sequences—to the ER membrane via the SRP[1][2][3]. SRPRA interacts directly with the SRP54 subunit of the SRP and is necessary for the transfer of the nascent protein from SRP to the protein translocation apparatus (translocon) within the ER, thus playing a critical role in proper protein sorting and secretion[1][2][5]. Loss or dysfunction of SRPRA disrupts protein secretion, leads to defects in cell growth, and has been implicated in congenital neutropenia and related disorders[4][5].

Other names
Signal recognition particle receptor subunit alphaSRPRASRPRSR-alphaDP-alphaSRP-alphaSralphaDocking protein alphaDPsignal recognition particle receptor alpha subunitdocking protein alphasignal recognition particle receptor (docking protein)
02

Mechanism of action

Not directly drug-targeted; the primary mechanism is GTP-dependent interaction with SRP and mediation of protein translocation into the endoplasmic reticulum.

03

Biological functions

Protein targeting and translocation to the endoplasmic reticulumCotranslational targeting of secretory and membrane proteinsGTP-dependent interaction with the signal recognition particle (SRP) complexRegulation of protein secretion and cell growth
04

Disease associations

Congenital neutropeniaShwachman-Diamond syndromePotential indirect involvement in disorders of protein trafficking and secretion
05

Safety considerations

No well-characterized direct drug safety concerns, but disruption of function causes severe defects in protein secretion and cell viability, indicating essentiality for cell function[4][5].

Beyond the preview

Go deeper on Signal recognition particle receptor subunit alpha (SRPRA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal recognition particle receptor subunit alpha (SRPRA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call